Arafat AMA, Botros SKA, Afifi R, Zayed SA, Fateen M. Serum Level of High-Mobility Group Box Protein 1 as a Potential Treatment Target in Egyptian Sickle Cell Disease Patients. Open Access Maced J Med Sci [Internet]. 2022 Apr. 23 [cited 2024 May 7];10(B):1072-8. Available from: https://oamjms.eu/index.php/mjms/article/view/8868